pembrolizumab
merck
['gyn', 'keynote826']
subgroup analyses of all subgroups in #keynote826 showed improvement in outcomes for recurrent or metastatic #cervicalcancer. #gyncsm #asco22 
I am a Gynecologic Oncologist with research focused on #cervicalcancerprevention #HPVcancerprevention, improving #HPVvaccine rates.